Themis Medicare Limited has informed the Exchange about Memorandum of Understanding/Agreements
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has signed an MoU with Gedeon Richter Plc, Hungary, its existing joint venture partner in Richter Themis Medicare Limited (RTML). Under this MoU, Themis Medicare will receive a management fee of USD 440,000 or 3% of RTML's net revenue, whichever is higher, subject to RTML meeting certain performance targets. The fee is compensation for Themis Medicare's contribution in developing new business opportunities, managing regulatory compliance, and providing corporate governance support to RTML. The arrangement formalizes the operational and financial relationship with its international JV partner.
This is a positive but modest development for shareholders, as it guarantees a recurring revenue stream for Themis Medicare from its JV with a reputed global pharmaceutical partner. However, the immediate financial impact is small relative to the company's overall size, so the stock price reaction is likely to be limited unless this signals deeper collaboration or expansion in the future.